Each dot is one of the 32 Diagnostic Equipment stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 6.9% and the median P/E 34.13. Pinned to the edge: 0 outliers on X and 3 on Y.
Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.
| # | Industry | ||||
|---|---|---|---|---|---|
| 1 | TMOThermo Fisher Scientific | 7.2% | 36.20 | $252.21B | Life Sciences Tools |
| 2 | ABTAbbott Laboratories | 8.1% | 33.29 | $180.61B | Medical Devices |
| 3 | DHRDanaher | 4.6% | 40.82 | $163.46B | Life Sciences Tools |
| 4 | ISRGIntuitive Surgical | 20.5% | 52.88 | $156.38B | Medical Devices |
| 5 | MDTMedtronic | 9.8% | 23.05 | $120.60B | Medical Devices |
| 6 | CAHCardinal Health | 14.2% | 34.62 | $59.34B | Drug Distribution |
| 7 | BDXBecton Dickinson | 17.4% | 56.97 | $53.61B | Medical Supplies |
| 8 | AAgilent Technologies | 8.6% | 34.41 | $49.56B | Life Sciences Tools |
| 9 | IDXXIdexx Laboratories | 12.8% | 39.44 | $44.95B | Animal Health |
| 10 | ILMNIllumina | 4.9% | 49.50 | $40.83B | Life Sciences Tools |
| 11 | GEHCGE HealthCare Technologies | 6.5% | 16.36 | $32.47B | Diagnostic Equipment |
| 12 | PHGKoninklijke Philips | 6.1% | 13.65 | $25.16B | Diagnostic Equipment |
| 13 | FTVFortive | 5.6% | 34.31 | $18.34B | Industrial Machinery |
| 14 | RVTYRevvity | 4.1% | 75.27 | $17.88B | Life Sciences Tools |
| 15 | COOCooper Companies | 4.7% | 20.64 | $11.77B | Medical Devices |
| 16 | TECHBio-Techne | -0.4% | 62.33 | $11.33B | Life Sciences Tools |
| 17 | QGENQiagen | 3.0% | 26.73 | $10.94B | Life Sciences Tools |
| 18 | BIOBio-Rad Laboratories | 1.4% | 44.84 | $9.97B | Life Sciences Tools |
| 19 | LNTHLantheus Holdings | 2.3% | 23.65 | $6.51B | Diagnostic Equipment |
| 20 | STVNStevanato Group S.p.A | 14.8% | 33.95 | $5.33B | Medical Supplies |
| 21 | VCYTVeracyte | 17.3% | 33.50 | $3.84B | Diagnostic Labs |
| 22 | MIRMirion Technologies | 15.7% | 148.29OUT | $3.63B | Nuclear Equipment |
| 23 | CDNACareDx | 34.4% | 31.81 | $3.53B | Diagnostic Labs |
| 24 | OSISOsi Systems | 4.3% | 21.18 | $3.28B | Defense |
| 25 | SXIStandex International | 12.8% | 28.23 | $2.95B | Industrial Machinery |
| 26 | VREXVarex Imaging | 5.3% | 35.09 | $775.48M | Diagnostic Equipment |
| 27 | MLABMesa Laboratories | 3.0% | 153.74OUT | $737.96M | Life Sciences Tools |
| 28 | RELLRichardson Electronics | 13.9% | 31.79 | $271.25M | Electrical Equipment |
| 29 | VASOVaso | 3.4% | 20.43 | $51.04M | Medical Devices |
| 30 | PRPOPrecipio | 23.0% | 113.81OUT | $34.37M | Diagnostic Labs |
| 31 | USAQQHSLab | 26.3% | 7.41 | $3.39M | Healthcare IT |
| 32 | ESMCEscalon Medical | 5.7% | 0.67 | $1.26M | Medical Devices |
Among Diagnostic Equipment stocks, the largest companies growing revenue faster than the median (6.9%) while trading below the median P/E (34.13) are Abbott Laboratories (ABT), Medtronic (MDT), Stevanato Group S.p.A (STVN), Veracyte (VCYT) and CareDx (CDNA). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.
The largest companies with a P/E above the median and revenue growth below it are Danaher (DHR), Illumina (ILMN), Fortive (FTV), Revvity (RVTY) and Bio-Techne (TECH).
The median P/E across the 32 Diagnostic Equipment stocks plotted is 34.13, with the middle half between 23.50 and 46.01.
The median is 6.9%, with the middle half between 4.5% and 14.4%.
The rank correlation (Spearman) is 0.02, a no meaningful positive relationship: knowing one tells you little about the other.
A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 0 companies are outliers on Revenue Growth (1y) (TTM) and 3 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.
Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.